Table of Contents:
  • Current status of and challenges in the research into therapeutic interventions for antiphospholipid syndrome (APS)
  • The hurdles pharmaceutical companies are facing on their way to developing APS treatments
  • Dealing with increased cardiovascular risks in patients with rheumatic autoimmune diseases
  • Challenges in lupus clinical trials
  • Current challenges in developing chronic musculoskeletal pain treatments